Showing results (191-200 of 205) with videos related to
Sort By:
Pageof 21
International Journal of Cardiology|August 18, 2020
Safety and efficacy of non-vitamin K antagonist oral anticoagulants for prevention of thromboembolism in adults with systemic right ventricle: Results from the NOTE international registryGiancarlo Scognamiglio, Flavia Fusco, Tara C Hankel, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2022
Single-Nucleotide Variants and Epimutations Induce Proteasome Inhibitor Resistance in Multiple MyelomaLarissa Haertle, Santiago Barrio, Umair Munawar, et al.European Journal of Haematology|July 26, 2020
Clinical course and risk factors for mortality from COVID-19 in patients with haematological malignanciesJosé María Sanchez-Pina, Mario Rodríguez Rodriguez, Nerea Castro Quismondo, et al.Kidney International Reports|February 12, 2024
Impact of Remote Monitoring on Standardized Outcomes in Nephrology-Peritoneal DialysisFrancisco Javier Centellas-Pérez, Agustín Ortega-Cerrato, Manel Vera, et al.British Journal of Haematology|June 3, 2017
Use of eltrombopag for secondary immune thrombocytopenia in clinical practiceTomás J González-López, María T Alvarez-Román, Cristina Pascual, et al.British Journal of Haematology|December 19, 2014
Use of eltrombopag after romiplostim in primary immune thrombocytopeniaJosé Ramón González-Porras, María Eva Mingot-Castellano, Marcio M Andrade, et al.Journal for Immunotherapy of Cancer|March 6, 2026
Antibiotic-associated dysbiosis and bispecific antibody outcomes in multiple myelomaMagdalena Corona, Roberto García-Vicente, Adolfo Jesús Saez-Marin, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 13, 2025
The Potential of the Gut Microbiota and Butyrate to Enhance CAR-T Cell Therapy in Non-Hodgkin LymphomaRoberto Garcia-Vicente, Alba Rodríguez-García, Raquel Ancos-Pintado, et al.Hemasphere|June 22, 2026
Minimally invasive characterization of peripheral blood measurable residual disease in multiple myeloma using high-sensitivity detection of ctDNA by next-generation sequencingNatalia Buenache, Marta Lasa, Andrés Arroyo, et al.Haematologica|November 30, 2023
Recovery of uninvolved heavy/light chain pair immunoparesis in newly diagnosed transplant-eligible myeloma patients complements the prognostic value of minimal residual disease detectionSunil Lakhwani, Laura Rosiñol, Noemí Puig, et al.Pageof 21